# A Single-Dose, Pharmacokinetic/Pharmacodynamic (PK/PD), & Safety Study of BIIB017 in Participants With Renal Impairment & Healthy Volunteers

> **NCT01119781** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 35 (actual)

## Conditions studied

- Healthy
- Renal Insufficiency

## Interventions

- **DRUG:** BIIB017(peginterferon beta-1a)

## Key facts

- **NCT ID:** NCT01119781
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2014-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01119781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01119781, "A Single-Dose, Pharmacokinetic/Pharmacodynamic (PK/PD), & Safety Study of BIIB017 in Participants With Renal Impairment & Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01119781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*